Role of phosphorylation in regulation of the assembly of endocytic coat complexes

Science

Volumn 281, Issue 5378, 1998, Pages 821-824

  Slepnev, Vladimir I ^a   Ochoa, Gian Carlo ^a   Butler, Margaret H ^a   Grabs, Detlev ^a   De Camilli, Pietro ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIPHYSIN; CELL PROTEIN; CLATHRIN; DYNAMIN; MEMBRANE PROTEIN; SYNAPTOJANIN 1; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; DEPHOSPHORYLATION; DEPOLARIZATION; ENDOCYTOSIS; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SYNAPSE VESICLE;

ADAPTOR PROTEIN COMPLEX ALPHA SUBUNITS; ADAPTOR PROTEIN COMPLEX BETA SUBUNITS; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ADENOSINE TRIPHOSPHATE; ANIMALS; BINDING SITES; CARBAZOLES; CHROMATOGRAPHY, AFFINITY; CLATHRIN; CYCLOSPORINE; DIMERIZATION; DYNAMIN I; DYNAMINS; ENDOCYTOSIS; ENZYME INHIBITORS; GTP PHOSPHOHYDROLASES; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; PHOSPHORIC MONOESTER HYDROLASES; RATS; RECOMBINANT FUSION PROTEINS; SRC HOMOLOGY DOMAINS;

ANIMALIA;

EID: 0032493929     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.281.5378.821     Document Type: Article

References (53)

1. J. E. Heuser and T. S. Reese, J. Cell Biol. 57, 315 (1973); O. Cremona and P. De Camilli, Curr. Opin. Neurobiol. 7, 323 (1997).
2. J. E. Heuser and T. S. Reese, J. Cell Biol. 57, 315 (1973); O. Cremona and P. De Camilli, Curr. Opin. Neurobiol. 7, 323 (1997).
3. J. H. Koenig and K. Ikeda, J. Neurosci. 9, 3844 (1989); K. Takei, P. S. McPherson, S. L. Schmid, P. De Camilli, Nature 374, 186 (1995) ; J. E. Hinshaw and S. L. Schmid, ibid., p. 190; R. Urrutia, J. R. Henley, T. Cook, M. A. McNiven, Proc. Natl. Acad. Sci. U.S.A. 94, 377 (1997).
4. J. H. Koenig and K. Ikeda, J. Neurosci. 9, 3844 (1989); K. Takei, P. S. McPherson, S. L. Schmid, P. De Camilli, Nature 374, 186 (1995) ; J. E. Hinshaw and S. L. Schmid, ibid., p. 190; R. Urrutia, J. R. Henley, T. Cook, M. A. McNiven, Proc. Natl. Acad. Sci. U.S.A. 94, 377 (1997).
5. J. H. Koenig and K. Ikeda, J. Neurosci. 9, 3844 (1989); K. Takei, P. S. McPherson, S. L. Schmid, P. De Camilli, Nature 374, 186 (1995) ; J. E. Hinshaw and S. L. Schmid, ibid., p. 190; R. Urrutia, J. R. Henley, T. Cook, M. A. McNiven, Proc. Natl. Acad. Sci. U.S.A. 94, 377 (1997).
6. J. H. Koenig and K. Ikeda, J. Neurosci. 9, 3844 (1989); K. Takei, P. S. McPherson, S. L. Schmid, P. De Camilli, Nature 374, 186 (1995) ; J. E. Hinshaw and S. L. Schmid, ibid., p. 190; R. Urrutia, J. R. Henley, T. Cook, M. A. McNiven, Proc. Natl. Acad. Sci. U.S.A. 94, 377 (1997).
7. P. S. McPherson et al., Nature 379, 353 (1996); C. Haffner et al., FEBS Lett. 419, 175 (1997).
8. P. S. McPherson et al., Nature 379, 353 (1996); C. Haffner et al., FEBS Lett. 419, 175 (1997).
9. P. Wigge et al., Mol. Biol. Cell 8, 2003 (1997).
10. B. Lichte, R. W. Veh, H. E. Meyer, M. W. Kilimann, EMBO J. 11, 2521 (1992); M. H. Butler et al., J. Cell Biol. 137, 1355 (1997); C. Leprince et al., J. Biol. Chem. 272, 15101 (1997); A. R. Ramjaun, K. D. Micheva, I. Bouhelet, P. S. McPherson, ibid., p. 16700.
11. B. Lichte, R. W. Veh, H. E. Meyer, M. W. Kilimann, EMBO J. 11, 2521 (1992); M. H. Butler et al., J. Cell Biol. 137, 1355 (1997); C. Leprince et al., J. Biol. Chem. 272, 15101 (1997); A. R. Ramjaun, K. D. Micheva, I. Bouhelet, P. S. McPherson, ibid., p. 16700.
12. B. Lichte, R. W. Veh, H. E. Meyer, M. W. Kilimann, EMBO J. 11, 2521 (1992); M. H. Butler et al., J. Cell Biol. 137, 1355 (1997); C. Leprince et al., J. Biol. Chem. 272, 15101 (1997); A. R. Ramjaun, K. D. Micheva, I. Bouhelet, P. S. McPherson, ibid., p. 16700.
13. B. Lichte, R. W. Veh, H. E. Meyer, M. W. Kilimann, EMBO J. 11, 2521 (1992); M. H. Butler et al., J. Cell Biol. 137, 1355 (1997); C. Leprince et al., J. Biol. Chem. 272, 15101 (1997); A. R. Ramjaun, K. D. Micheva, I. Bouhelet, P. S. McPherson, ibid., p. 16700.
14. C. David, M. Solimena, P. De Camilli, FEBS Lett. 351, 73 (1994).
15. C. David, P. S. McPherson, O. Mundigl, P. De Camilli, Proc. Natl. Acad. Sci. U.S.A. 93, 331 (1996).
16. D. Grabs et al., J. Biol. Chem. 272, 13419 (1997).
17. O. Shupliakov et al., Science 276, 259 (1997); P. Wigge, Y. Vallis, H. T. McMahon, Curr. Biol. 7, 554 (1997).
18. O. Shupliakov et al., Science 276, 259 (1997); P. Wigge, Y. Vallis, H. T. McMahon, Curr. Biol. 7, 554 (1997).
19. H. T. McMahon, P. Wigge, C. Smith, FEBS Lett. 413, 319 (1997).
20. A. R. Ramjaun and P. S. McPherson, Mol. Biol. Cell Suppl. 8, 93a (1997).
21. L. H. Wang, T. C. Südhof, R. G. W. Anderson, J. Biol. Chem. 270, 10079 (1995).
22. 2, and 1% Triton X-100; centrifuged at 40,000g for 30 min; and incubated with beads for 4 hours at 4°C. Beads were washed five times with 20 mM Hepes (pH 7.4), 150 mM NaCl, and 1% Triton X-100 and eluted with SDS-PAGE sample buffer. Eluted proteins were separated by SDS-PAGE and stained with Coomassie blue or transferred to nitrocellulose filters for immunoblot analysis. Recombinant human amphiphysin 1, its SH3 domain (6), and its central region (amino acids 262 to 435) (6) were expressed in pGEX6 vector as GST-fused proteins. Their purification and removal of GST by using PreScission protease (Pharmacia) were performed according to the manufacturer's protocols. For competition experiments, 30 μg of PRD presorbed to glutathione-Sepharose was supplemented with 5 or 15 μg of amphiphysin 1, 150 μg of the SH3 domain of amphiphysin, or 150 μg of the central region (amino acids 262 to 435) and incubated with 1 ml of extract for 2 hours at 4°C.
23. B. M. Pearse and M. S. Robinson, Annu. Rev. Cell Biol. 6, 151 (1990).
24. A number of other nerve terminal proteins tested, including the synaptic vesicle proteins synaptobrevin, synaptotagmin, and Rab3, did not bind to the PRD.
25. P. P. Di Fiore, P. G. Pelicci, A. Sorkin, Trends Biochem. Sci. 22, 411 (1997); S. Ahle and E. Ungewickell, EMBO J. 5, 3143 (1986); S. Zhou et al., J. Biol. Chem. 268, 12655 (1993).
26. P. P. Di Fiore, P. G. Pelicci, A. Sorkin, Trends Biochem. Sci. 22, 411 (1997); S. Ahle and E. Ungewickell, EMBO J. 5, 3143 (1986); S. Zhou et al., J. Biol. Chem. 268, 12655 (1993).
27. P. P. Di Fiore, P. G. Pelicci, A. Sorkin, Trends Biochem. Sci. 22, 411 (1997); S. Ahle and E. Ungewickell, EMBO J. 5, 3143 (1986); S. Zhou et al., J. Biol. Chem. 268, 12655 (1993).
28. N. Ringstad, Y. Nemoto, P. De Camilli, Proc. Natl. Acad. Sci. U.S.A. 94, 8569 (1997); E. de Heuvel et al., J. Biol. Chem. 272, 8710 (1997).
29. N. Ringstad, Y. Nemoto, P. De Camilli, Proc. Natl. Acad. Sci. U.S.A. 94, 8569 (1997); E. de Heuvel et al., J. Biol. Chem. 272, 8710 (1997).
30. J. H. Keen and M. M. Black, J. Cell Biol. 102, 1325 (1986) ; S. A. Morris, A. Mann, E. Ungewickell, J. Biol. Chem. 265, 3354 (1990); W. J. Schook and S. Puszkin, Proc. Natl. Acad. Sci. U.S.A. 82, 8039 (1985).
31. J. H. Keen and M. M. Black, J. Cell Biol. 102, 1325 (1986) ; S. A. Morris, A. Mann, E. Ungewickell, J. Biol. Chem. 265, 3354 (1990); W. J. Schook and S. Puszkin, Proc. Natl. Acad. Sci. U.S.A. 82, 8039 (1985).
32. J. H. Keen and M. M. Black, J. Cell Biol. 102, 1325 (1986) ; S. A. Morris, A. Mann, E. Ungewickell, J. Biol. Chem. 265, 3354 (1990); W. J. Schook and S. Puszkin, Proc. Natl. Acad. Sci. U.S.A. 82, 8039 (1985).
33. A. Wilde and F. M. Brodsky, J. Cell Biol. 135, 635 (1996).
34. P. J. Robinson et al., Nature 365, 163 (1993); P. S. McPherson, K. Takei, S. L. Schmid, P. De Camilli, J. Biol. Chem. 269, 30132 (1994).
35. P. J. Robinson et al., Nature 365, 163 (1993); P. S. McPherson, K. Takei, S. L. Schmid, P. De Camilli, J. Biol. Chem. 269, 30132 (1994).
36. R. Bauerfeind, K. Takei, P. De Camilli, J. Biol. Chem. 272, 30984 (1997).
37. 2+ up to 50 μM or of 0.2 mM ECTA during the phosphorylation reaction did not produce significant differences on the results of coimmunoprecipitations. A nonhydrolyzable analog of ATP, adenosine-5′-(γ-thio)triphosphate, was not effective in preventing complex formation. No protein bands were precipitated by control immunoglobulin G. For experiments in Fig. 2, B to G, extracts were incubated in the presence of 2 to 5 mM ATP and phosphatase inhibitor mixture (phosphorylation conditions are denoted as +ATP) or in the presence of 4 μM K252a (dephosphorylation conditions are denoted as -ATP).
38. Metabolic labeling of intact rat synaptosomes confirmed that the upper band of amphiphysin 2 represents a phosphorylated form of the protein.
39. The reverse experiment, in which ATP-pretreated material was applied to a dynamin 1 PRD column, did not reveal significant differences in binding of amphiphysins 1 and 2.
40. C-adaptin cloned into pGEX4T-1) vector was bound to glutathione Sepharose-4B beads (Pharmacia).
41. 32P-labeled dynamin 1, synaptojanin 1, or AP-2 components from metabolically labeled synaptosomes.
42. 2, 5 mM ATP, and the following inhibitors: 2 μM cyclosporin A, 0.2 μM okadaic acid, 1 mM sodium vanadate, and a mixture of the three.
43. U. T. Ruegg and G. M. Burgess, Trends Pharmacol. Sci. 10, 218 (1989).
44. D. Toullec et al., J. Biol. Chem. 266, 15771 (1991); E. Kobayashi, H. Nakano, M. Morimoto, T. Tamaoki, Biochem. Biophys. Res. Commun. 159, 548 (1989).
45. D. Toullec et al., J. Biol. Chem. 266, 15771 (1991); E. Kobayashi, H. Nakano, M. Morimoto, T. Tamaoki, Biochem. Biophys. Res. Commun. 159, 548 (1989).
46. M. Sumi et al., Biochem. Biophys. Res. Commun. 181, 968 (1991).
47. A fragment of cDNA encoding amino acids 250 to 588 of amphiphysin 1 [B/C region (6)] was subcloned into pcDNA3 vector (Invitrogen) and transiently transfected into CHO cells for 24 hours. CY3-labeled transferrin (Molecular Probes) (25 μg/ml final concentration) was added during the last 25 min before a short wash in phosphate-buffered saline. Cells were fixed with formaldehyde and processed for immunofluorescence with antibody X22 to clathrin (ATCC) and antibody CD6 to amphiphysin (6).
48. B. Ceccarelli and W. P. Hurlbut, J. Cell Biol. 87, 297 (1980); O. Shupliakov, H. Gad, P. Low, E. Zotova, L. Brodin, Soc. Neurosci. Abstr. 23, 2274 (1997).
49. B. Ceccarelli and W. P. Hurlbut, J. Cell Biol. 87, 297 (1980); O. Shupliakov, H. Gad, P. Low, E. Zotova, L. Brodin, Soc. Neurosci. Abstr. 23, 2274 (1997).
50. E. M. Merisko, M. G. Farquhar, G. E. Palade, Pancreas 1, 110 (1986); K. L. English and M. C. Nowicky, J. Physiol (London) 506, 591 (1998) ; O. Shupliakov et al., Soc. Neurosci. Abstr. 22, 777 (1996).
51. E. M. Merisko, M. G. Farquhar, G. E. Palade, Pancreas 1, 110 (1986); K. L. English and M. C. Nowicky, J. Physiol (London) 506, 591 (1998) ; O. Shupliakov et al., Soc. Neurosci. Abstr. 22, 777 (1996).
52. E. M. Merisko, M. G. Farquhar, G. E. Palade, Pancreas 1, 110 (1986); K. L. English and M. C. Nowicky, J. Physiol (London) 506, 591 (1998) ; O. Shupliakov et al., Soc. Neurosci. Abstr. 22, 777 (1996).
53. We thank C. David for help and discussion in the initial experiments and T. Kirchhausen, P. P. Di Fiore, and R. Jahn for the generous gift of antibodies. Supported in part by grants from the NIH (CA46128 and NS36251), by the Human Frontier Science Program and the U.S. Army Medical Research and Development Command to P.D.C., and by a fellowship from the Deutscher Akademischer Austauschdienst to D.G.